GlassScriptPhysician profile
Nilesh M Doshi
NPI 1518929272
$16,664.77
in general payments reported to CMS, 2019-2025
11 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,907 · 2020: $3,513 · 2021: $5,855 · 2022: $899 · 2023: $26.74 · 2024: $358 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $491.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $14,109.74 | 2019-2025 | Indigo System, Ruby Coil |
| Cardiovascular Systems INC. | $913.42 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $468.55 | 2019-2021 | |
| Shockwave Medical, INC | $406.45 | 2021-2022 | |
| Getinge USA Sales, LLC | $234.65 | 2019-2021 | |
| Inari Medical, INC. | $193.72 | 2022 | |
| Terumo Medical Corporation | $131.32 | 2020 | |
| Vasorum USA INC. | $125.20 | 2024 | Celt Acd |
| Siemens Medical Solutions USA, INC. | $35.81 | 2022 | |
| Cook Medical LLC | $30.18 | 2019 | |
| Boston Scientific Corporation | $15.73 | 2024 | Wavewriter Alpha Prime 16 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nilesh Doshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.